person · Reporting owner
KRAEMER HARRY M JANSEN JR
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 12, 2024 | January 16, 2024 |
| Leidos Holdings, Inc.LDOS · Entity 668 | Director | October 07, 2026 | October 09, 2026 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 12, 2024 · Filed January 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,351.467 |
Reported balance
After 2024-01-12 transaction · row 1
1 source rowRow 1 · 2024-01-12 · Grant · Acquired 46.076 · Balance 148,351.467 F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 2,758.1977 |
Reported balance
After 2024-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-12 · Grant · Acquired 10.4546 · Balance 2,758.1977 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Leidos Holdings, Inc.
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Key Executive Stock Deferral Plan | 132,108.0146 |
Reported balance
After 2026-10-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 297.2259 · Balance 132,108.0146 F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. |
| Common StockSEC Table I · non-derivative | Direct | 93,281 |
Reported balance
Holding disclosure · report date 2026-10-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 93,281 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 471,076 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 458,997 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 12,079 · Balance 471,076 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VWR Corp
Report date November 21, 2017 · Filed November 22, 2017
Section 16 reporting ended · disclosed 2017-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 1
1 source rowRow 1 · 2017-11-21 · Disposition to issuer · Disposed 7,617 · Balance 0 F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. |
| Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.00 · Expires 2021-10-01 | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-21 · Disposition to issuer · Disposed 22,617 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.
F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2023 Filed Oct 16, 2023 21:01 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 74.253 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025914 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,305.391 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they related. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 729.2413 | $34.28 | $24,998.39 |
DisclosureSEC source: 0001127602-23-024990 · form4.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,035.7505 Underlying: Common Stock · 729.2413 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:40 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 482.3621 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-033684 · wk-form4_1696369192.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 122,927.7223 F1 · shares: Dividend equivalent rights. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 21:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 55,000 | $34.63 | $1,904,518.00 |
DisclosureSEC source: 0001437749-23-023865 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,528 F1 · price: Reflects the weighted average price of 55,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 11, 2023 with purchase prices ranging from $34.55 to $34.7375 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,193 | $0.00 Strike: $39.70 | $0.00 |
DisclosureSEC source: 0001628280-23-027806 · wk-form4_1691440725.xml · derivative · entry 5 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,193 shares Expires 2023-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 3,098 | $96.95 | $300,360.39 |
DisclosureSEC source: 0001628280-23-027806 · wk-form4_1691440725.xml · nonDerivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,277 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices from $96.89 to $96.9950 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 2,095 | $98.40 | $206,148.00 |
DisclosureSEC source: 0001628280-23-027806 · wk-form4_1691440725.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,375 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 5,193 | $39.70 | $206,162.10 |
DisclosureSEC source: 0001628280-23-027806 · wk-form4_1691440725.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 21:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 4.4308 | $41.14 | $182.28 |
DisclosureSEC source: 0001127602-23-020832 · form4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,306.5092 Underlying: Common Stock · 4.4308 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 21:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 75.005 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020832 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,231.138 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:43 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 504.2526 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-024274 · wk-form4_1688589792.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 122,445.3602 F1 · shares: Dividend equivalent rights. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 21:09 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 631.6321 | $39.58 | $25,000.00 |
DisclosureSEC source: 0001127602-23-019570 · form4.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,302.0784 Underlying: Common Stock · 631.6321 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock and accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016974 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,156.133 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 17, 2023 Filed Jun 7, 2023 20:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 12,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016876 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,528 F1 · shares: The reporting person received an award of restricted stock units on May 17, 2023, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $356,000 of value based on the closing price of the issuer's common stock on May 17, 2023. Read SEC document |
| May 05, 2023 Filed May 9, 2023 23:31 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 2,296 | $0.00 Strike: $79.45 | $0.00 |
DisclosureSEC source: 0001628280-23-016964 · wf-form4_168367508183755.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,296 Underlying: Common Stock · 2,296 shares Expires 2030-05-04 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 05, 2023 Filed May 9, 2023 23:31 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-016964 · wf-form4_168367508183755.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 121,941.1076 Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:52 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 17.3 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-014892 · wf-form4_168306069260976.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 120,367.1076 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 2.2756 | $41.11 | $93.55 |
DisclosureSEC source: 0001127602-23-013146 · form4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670.4463 Underlying: Common Stock · 2.2756 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 56.902 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013146 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,737.133 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:43 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 476.9874 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-010640 · wf-form4_168064099458978.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 120,349.8076 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 20:24 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 668.1707 | $37.42 | $25,002.95 |
DisclosureSEC source: 0001127602-23-011562 · form4.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668.1707 Underlying: Common Stock · 668.1707 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:34 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 6,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007073 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,898 F1 · shares: The restricted stock units granted in this award vest in three equal installments of the underlying shares of Common Stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 21:57 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 62.43 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001410 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,680.231 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 00:04 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 414.5298 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000140 · wf-form4_167279068046875.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 119,872.8202 F1 · shares: Dividend equivalent rights. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:38 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025779 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,617.801 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 20:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 41.793 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-024090 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,235.801 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:24 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 492.1778 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-22-000047 · wf-form4_166491504492196.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 119,458.2904 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:53 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 32.122 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019188 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,194.008 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:01 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 434.8689 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018497 · wf-form4_165705484089419.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 118,966.1126 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,523 | $0.00 Strike: $31.62 | $0.00 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · derivative · entry 5 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,523 shares Expires 2022-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequentlyadjusted to reflect a special dividend declared by the issuer in August 2016. F2 · derivative.underlying_shares: This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequentlyadjusted to reflect a special dividend declared by the issuer in August 2016. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | SaleCommon Stock | 7,274 | $103.18 | $750,531.32 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,277 Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 3,249 | $102.39 | $332,665.11 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,551 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 26, 2022 Filed May 31, 2022 21:44 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 10,523 | $31.62 | $332,766.72 |
DisclosureSEC source: 0001628280-22-015789 · wf-form4_165403344523390.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 24, 2022 22:07 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 9,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015474 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,965 F1 · price: The reporting person received an award of restricted stock units on May 20, 2022. The number of restricted stock units granted was calculated to reflect $276,000 of value based on the closing price of the issuer's common stock on May 19, 2022. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:02 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,784 | $0.00 Strike: $104.06 | $0.00 |
DisclosureSEC source: 0001628280-22-013646 · wf-form4_165221655395474.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Underlying: Common Stock · 1,784 shares Expires 2029-05-05 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:02 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013646 · wf-form4_165221655395474.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 118,531.2437 Read SEC document |
| April 29, 2022 Filed May 2, 2022 20:31 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 14.3176 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011740 · wf-form4_165152343677382.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 117,425.2437 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:57 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 36.191 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011851 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,161.886 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 23:13 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 393.6188 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008295 · wf-form4_164911398734848.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 117,410.9261 F1 · shares: Dividend equivalent rights. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 23:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.662 | $0.00 | $0.00 |
DisclosureSEC source: 0001306483-22-000002 · primary_doc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,125.695 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they related. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:48 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 481.0205 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-000112 · wf-form4_164124650757663.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 117,017.3073 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:55 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 26.271 | $60.01 | $1,576.52 |
DisclosureSEC source: 0001127602-21-026971 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,120.033 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:13 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 432.3361 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-019586 · wf-form4_163338200737230.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 116,536.2868 F1 · shares: Dividend equivalent rights. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:05 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock, par value $0.0001 | 44,742 | $21.47 | $960,498.89 |
DisclosureSEC source: 0001104659-21-107326 · tm2124220-5_4seq1.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,410 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.30 to $21.77. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:05 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock, par value $0.0001 | 5,258 | $21.45 | $112,809.34 |
DisclosureSEC source: 0001104659-21-107326 · tm2124220-5_4seq1.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,668 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.18 to $21.55. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:01 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 24.522 | $64.18 | $1,573.82 |
DisclosureSEC source: 0001127602-21-021892 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,093.762 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:18 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 394.9316 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-013449 · wf-form4_162525707632286.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 116,103.9507 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018520 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,069.24 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:07 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock, par value $0.0001 | 16,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074145 · tm2117815-4_4seq1.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,410 F1 · shares: The reporting person received an award of restricted stock units on May 26, 2021. The number of restricted stock units granted was calculated to reflect $294,500 of value based on the closing price of the issuer's common stock on May 19, 2021, the date of the annual meeting at which directors were elected. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:44 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock, par value $0.0001 | 40,000 | $17.59 | $703,656.00 |
DisclosureSEC source: 0001104659-21-070036 · tm2117111-1_4seq1.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,760 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.45 to $17.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.